Docusign (NASDAQ:DOCU) Stock Price Target Raised at BTIG Research

Docusign (NASDAQ:DOCU – Get Free Report) had its price target boosted by stock analysts at BTIG Research from $75.00 to $90.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research‘s price target would indicate a potential upside of 18.53% from the stock’s current price.

DOCU has been the topic of a number of other reports. Robert W. Baird increased their target price on shares of Docusign from $55.00 to $72.00 and gave the stock a “neutral” rating in a report on Friday, September 4th. UBS Group boosted their price target on shares of Docusign from $54.00 to $70.00 and gave the stock a “neutral” rating in a research note on Friday, September 4th. Yorkville Ives assumed coverage on Docusign in a research report on Monday, October 5th. They set an “in-line” rating and a $72.00 price objective on the stock. Royal Bank Of Canada upped their price objective on Docusign from $55.00 to $70.00 and gave the stock a “sector perform” rating in a research report on Friday, September 4th. Finally, Weiss Ratings upgraded Docusign from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Three equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $68.56.

Check Out Our Latest Research Report on DOCU

Docusign Stock Performance

NASDAQ DOCU opened at $75.93 on Wednesday. The firm has a 50 day simple moving average of $74.45 and a 200-day simple moving average of $56.02. Docusign has a one year low of $40.16 and a one year high of $85.90. The firm has a market cap of $14.19 billion, a price-to-earnings ratio of 46.30, a PEG ratio of 2.94 and a beta of 0.80.

Docusign (NASDAQ:DOCU – Get Free Report) last announced its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The firm had revenue of $875.75 million during the quarter, compared to analysts’ expectations of $867.22 million. During the same quarter in the previous year, the business posted $0.30 earnings per share. The business’s quarterly revenue was up 9.4% compared to the same quarter last year. Equities analysts predict that Docusign will post 2.15 EPS for the current fiscal year.

Insider Buying and Selling at Docusign

In related news, insider James Shaughnessy sold 12,000 shares of the company’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $68.80, for a total transaction of $825,600.00. Following the sale, the insider directly owned 50,591 shares in the company, valued at approximately $3,480,660.80. This represents a 19.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Peter Solvik sold 46,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $65.24, for a total transaction of $3,001,040.00. Following the completion of the sale, the director directly owned 49,558 shares in the company, valued at approximately $3,233,163.92. This trade represents a 48.14% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 154,168 shares of company stock valued at $10,491,896. 0.59% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Docusign

Hedge funds and other institutional investors have recently modified their holdings of the company. Integrated Wealth Concepts LLC grew its stake in shares of Docusign by 17.5% during the third quarter. Integrated Wealth Concepts LLC now owns 16,870 shares of the company’s stock worth $1,133,000 after purchasing an additional 2,511 shares in the last quarter. Snow Capital Management LLC purchased a new position in Docusign in the third quarter valued at $1,142,000. Allworth Financial LP increased its holdings in Docusign by 28.2% in the third quarter. Allworth Financial LP now owns 13,347 shares of the company’s stock valued at $896,000 after buying an additional 2,937 shares during the last quarter. Worldquant Millennium Advisors LLC raised its stake in Docusign by 74.4% in the third quarter. Worldquant Millennium Advisors LLC now owns 63,292 shares of the company’s stock valued at $4,250,000 after buying an additional 27,011 shares in the last quarter. Finally, Toronto Dominion Bank acquired a new stake in Docusign in the third quarter valued at $7,604,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Docusign Company Profile

(Get Free Report)

DocuSign, Inc. provides software for preparing, signing, managing and automating agreements. Its platform helps businesses and individuals complete agreements digitally, reducing reliance on paper-based processes. The company’s offerings include DocuSign eSignature, which enables users to sign and request signatures electronically, as well as tools for contract lifecycle management and agreement workflows. Its Intelligent Agreement Management products use artificial intelligence to help organizations analyze and manage agreement-related information and processes.

Featured Stories

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.